Next, Kaplan–Meier survival analysis with online tool (http://kmplot.com/analysis/) demonstrated that both enhanced LSD1 expression and higher PRMT5 expression were associated with shorter relapse-free survival (RFS) and overall survival (OS) of breast cancer patients (Fig. 6B). This evidence concerns the gene PRMT5 and breast carcinoma.